Year Established :
2013
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
100-500
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Small Orders Accepted,Quality Service
Other Competitive Advantages :
Well and High Quality Control ,
Prompt Delivery ,
Competitive Prices
Large new manufacturing base
Business Type :
Manufacturer
R&D Capacity :
Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
North America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Product Range :
PEG Derivatives: Thiol(SH) PEG, Carboxylic Acid (COOH) PEG, Hydroxyl (OH) PEG, Amine (NH2) PEG, Maleimide(Mal) PEG, Silane PEG, DBCO PEG, Fluorescent (FITC) PEG, Biotin PEG, Rhodamine B(RB) PEG, Cyanine (Cy) PEG, Acrylate(AC) PEG, Acrylamide(ACA) PEG, Aldehyde (Ald/CHO) PEG, Azide(N3) PEG, Hydrocarbons PEG, Cholesterol PEG , Folic Acid (FA) PEG, Lipoic Acid (LA) PEG, NPC PEG, OPSS PEG, Epoxide (EPO) PEG, NHS Ester PEG,
Pharma Intermediates: Carfilzomib Intermediates, Elagolix Intermediates,Oseltamivir Intermediates, Baloxavir Marboxil Intermediates,Semaglutide Intermediates, Liraglutide Intermediates, Sitagliptin Intermediates, Olmesartan Intermediates, Moxonidine Intermediates